Research Overview: MYO-29 Myostatin Inhibitor
MYO-29 is a synthetic myostatin inhibitor peptide engineered for advanced laboratory investigations into muscle protein synthesis regulation. This research compound enables scientists to examine myostatin’s role in skeletal muscle development and cellular growth pathways. Developed by St Biotechnology, MYO-29 provides researchers with a precise tool for studying the molecular mechanisms underlying muscle tissue regulation. Leading research facilities worldwide utilise myostatin inhibitors to investigate therapeutic applications for muscle wasting conditions and developmental biology. Stroid UK Shop supplies this compound exclusively for qualified research institutions conducting in-vitro studies.
Laboratory Research Applications
Research scientists investigate MYO-29’s effects on myostatin-mediated signalling cascades in muscle cell cultures. Laboratory studies examine how myostatin inhibition influences satellite cell activation and muscle fibre hypertrophy pathways. Cellular biology researchers analyse the compound’s interaction with activin receptors and downstream SMAD protein signalling. Molecular biologists study MYO-29’s potential in understanding muscle regeneration mechanisms following tissue injury. Comparative studies with other peptides help elucidate specific myostatin inhibition pathways. Advanced research protocols investigate the compound’s effects on muscle-specific transcription factors and protein synthesis rates. Scientists examine MYO-29’s influence on muscle stem cell proliferation and differentiation in controlled laboratory environments. Research applications extend to studying age-related muscle loss mechanisms and potential therapeutic interventions. Laboratories utilise this compound alongside SARMs for comprehensive muscle biology investigations.
Technical Specifications
| Parameter | Specification |
|---|---|
| Molecular Weight | Verify with supplier |
| Chemical Formula | Verify with supplier |
| Purity | ≥98% HPLC verified |
| Presentation | 1mg lyophilised powder |
| Storage | -20°C, desiccated |
| Solubility | Water, DMSO compatible |
Research Compliance Statement
MYO-29 1mg St Biotechnology is manufactured exclusively for laboratory research applications. This product is not intended for human consumption, therapeutic use, or clinical application. Research institutions must handle this compound according to established laboratory safety protocols and regulatory guidelines.
